Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC.
Saved in:
| Title: | Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC. |
|---|---|
| Authors: | Koeck S; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Amann A; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Kern J; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria.; Department of Otorhinolaryngology, Head and Neck Surgery, Mannheim Medical Faculty of Heidelberg University, Mannheim, Germany., Zwierzina M; Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Innsbruck, Innsbruck, Austria., Lorenz E; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Sopper S; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Zwierzina H; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Mildner F; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Sykora M; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria., Sprung S; Department of Pathology, Neuropathology, and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Hackl H; Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Augustin F; Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Maier HT; Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Pircher A; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Pall G; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Wolf D; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria., Gamerith G; Department of Internal Medicine V, Medical University of Innsbruck, Innsbruck, Tyrol, Austria.; Tyrolean Cancer Research Institute, Innsbruck, Austria. |
| Source: | Oncoimmunology [Oncoimmunology] 2023 Nov 28; Vol. 12 (1), pp. 2274130. Date of Electronic Publication: 2023 Nov 28 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-402X |
|---|---|
| DOI: | 10.1080/2162402X.2023.2274130 |
